Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for impairment of transsulfuration pathway in cirrhosis.

Literature DB >> 7262512

Evidence for impairment of transsulfuration pathway in cirrhosis.

J H Horowitz, E B Rypins, J M Henderson, S B Heymsfield, S D Moffitt, R P Bain, R K Chawla, J C Bleier, D Rudman.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1981 PMID： 7262512

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

Keyword Cloud
Cited

× No keyword cloud information.

28 in total

Review 1. Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

Authors: Akshata Moghe; Swati Joshi-Barve; Smita Ghare; Leila Gobejishvili; Irina Kirpich; Craig J McClain; Shirish Barve
Journal: World J Gastroenterol Date: 2011-05-28 Impact factor: 5.742

2. Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine.

Authors: S Harvey Mudd; Conrad Wagner; Zigmund Luka; Sally P Stabler; Robert H Allen; Richard Schroer; Timothy Wood; Jing Wang; Lee-Jun Wong
Journal: Mol Genet Metab Date: 2011-11-12 Impact factor: 4.797

Review 3. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.

Authors: J M Mato; F Corrales; A Martin-Duce; P Ortiz; M A Pajares; C Cabrero
Journal: Drugs Date: 1990 Impact factor: 9.546

Review 7. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.

Authors: E Pisi; G Marchesini
Journal: Drugs Date: 1990 Impact factor: 9.546

Evidence for impairment of transsulfuration pathway in cirrhosis.

Review 1. Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

2. Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine.

Review 3. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.

Review 4. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.

5. Total plasma homocysteine: influence of some common physiological variables.

Review 6. Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Review 7. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.

Review 8. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.

9. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis.

Review 10. S-adenosylmethionine in liver health, injury, and cancer.